Diaceutics PLC (LON:DXRX - Get Free Report) insider Nick Roberts purchased 126 shares of Diaceutics stock in a transaction that occurred on Monday, April 28th. The shares were bought at an average price of GBX 119 ($1.58) per share, for a total transaction of £149.94 ($199.02).
Diaceutics Trading Down 0.7 %
Shares of LON:DXRX traded down GBX 0.90 ($0.01) during trading on Friday, reaching GBX 121.10 ($1.61). 38,584 shares of the company traded hands, compared to its average volume of 98,719. The company has a current ratio of 4.85, a quick ratio of 9.92 and a debt-to-equity ratio of 0.39. Diaceutics PLC has a 52-week low of GBX 95 ($1.26) and a 52-week high of GBX 151 ($2.00). The firm has a market capitalization of £102.20 million, a price-to-earnings ratio of -35.92 and a beta of 0.58. The business's fifty day moving average is GBX 123.41 and its 200-day moving average is GBX 127.34.
Diaceutics Company Profile
(
Get Free Report)
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.
See Also
Before you consider Diaceutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diaceutics wasn't on the list.
While Diaceutics currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.